IN8bio, Inc.

NASDAQ:INAB

0.2301 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -30.007-28.521-14.653-8.557-5.134-2.081
Depreciation & Amortization 2.5011.1030.7880.0880.0960.096
Deferred Income Tax 0.981-4.163-0.541000
Stock Based Compensation 4.373.4672.1950.3570.0760.031
Change In Working Capital -0.204-0.17-1.8390.6110.093-0.885
Accounts Receivables 00000.03-0.03
Inventory 0000-0.030
Accounts Payables -0.9811.51-0.319-0.160.141-0.152
Other Working Capital 0.777-1.68-1.520.771-0.048-0.733
Other Non Cash Items -0.9814.1630.5410.3680.0680.07
Operating Cash Flow -23.34-24.121-13.509-7.133-4.801-2.769
Investing Activities:
Investments In Property Plant And Equipment -0.6-3.705-0.3090-0.33-0.757
Acquisitions Net 00000.6860
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites -0.195-0.016-0.30900.0010
Investing Cash Flow -0.6-3.705-0.30900.356-0.757
Financing Activities:
Debt Repayment -0.798-0.615-0.709-0.1740-0.803
Common Stock Issued 27.8429.54236.3270.4990.0657.237
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 17.6580.061-2.66324.19209.304
Financing Cash Flow 27.0448.98832.95524.5170.0658.501
Other Information:
Effect Of Forex Changes On Cash -0.00400000
Net Change In Cash 3.1-18.83819.13717.384-4.384.975
Cash At End Of Period 21.28218.43437.27217.9940.614.99